Changes in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.
John J. Mahoney, MD
Advertisement
Articles by John J. Mahoney, MD
Advertisement
Latest Updated Articles
Value-Based Design and Prescription Drug Utilization Patterns Among Diabetes PatientsPublished: June 6th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
5
